Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : CLPR - Caliper Tech., Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Snow Shoe who wrote (6)	12/22/1999 2:47:00 PM
From: Andrew Danielson	Read Replies (1) \| Respond to of 12

Yes, it is rather quiet here. But I think that has less to do with a lack of enthusiasm for the company and more to do with a simple dearth of information. Until the quiet period ends, we don't even have press releases to go on. Articles and third-party analyses are also hard to come by. So we're left with spotty information, filled in partially by the prospectus. Personally, I love the technology the company is developing, even if I know little about the company itself. CALP's lab on a chip technology is a beautiful example of an enabling technology for the genetic revolution in drug development. As we come close to mapping the human genome and build up databases of human SNP's (single nucleotide polymorphisms), we will begin to apply and develop drugs that are tailored to a person's individual genetic profile. This kind of customization requires testing of compounds on a massive scale. Enter, CALP. I'm a big believer of the coming convergence of genetics and pharmaceuticals, and Caliper is in the sweet-spot of providing an enabling technology to help us get there. Andrew Danielson Long CALP, NGEN and AFFX